LISTS OF PROPOSED INNs
|
DOWNLOAD PRESCRIRE'S RESPONSE
|
EXAMPLES OF CHANGES MADE
|
> List 129 (2023)
|
> Prescrire's Response (129)
|
|
| > List 129 Covid-19 (special edition) (2023) |
> Prescrire's Response (129 Covid-19 special edition) (in French)
|
|
> List 128 (2023)
|
> Prescrire's Response (128)
|
|
| > List 128 Covid-19 Addendum1 (2022) |
> Prescrire's Response (128 Covid-19 Addendum1) (in French)
|
|
> List 128 - Covid-19 (2022)
|
> Prescrire's Response
(128 - Covid-19) (in French) |
|
| > List 127 (2022) |
> Prescrire's Response (127) |
• manusiran (replaced by divesiran in list 129) |
> List 127 - Covid-19 (2022)
|
> Prescrire's Response
(127 - Covid-19) (In French) |
|
> List 126 (2022)
|
> Prescrire's Response (126) |
|
> List 126 - Covid-19 (2022)
|
> Prescrire's Response
(126 - Covid-19) (In French) |
|
> List 125 (2021)
|
> Prescrire's Response (125) |
|
> List 125 - Covid-19 (2021)
|
> Prescrire's Response
(125 - Covid-19) (In French) |
|
> List 124 (2021)
|
> Prescrire's Response (124) |
|
> List 124 - Covid-19 (2020)
|
> Prescrire's Response (124 - Covid-19) |
|
> List 123 (2020)
|
> Prescrire's Response (123) |
• valiloxibic acid (replaced by valiloxybate in list 124)
• ensomafusp alfa (replaced by englumafusp alfa in list 127)
• pavunalimab (replaced by bavunalimab in list 125)
|
> List 122 (2020)
|
> Prescrire's Response (122) |
• icatolimab (replaced by tifcemalimab in list 124)
• rulabricine alfa (replaced by ledelabricin alfa in list 124) |
> List 121 (2019)
|
> Prescrire's Response (121) |
• mavezelimab (replaced by favezelimab in list 123) |
> List 120 (2019)
|
> Prescrire's Response (120) |
• nidanilimab (replaced by nadunolimab in list 122) |
> List 119 (2018)
|
> Prescrire's Response (119) |
• setogepram (replaced by fezagepras in list 121)
• talditercept alfa (replaced by taldefgrobep alfa in list 121) |
> List 118 (2018)
|
> Prescrire's Response (118) |
• abeprazan (replaced by fexuprazan in list 120)
• diroleuton (replaced by daleuton in list 123)
• nedisertib (replaced by peposertib in list 120)
• nemorexant (replaced by daridorexant in list 120)
• vanalimab (replaced by mitazalimab in list 119) |
> List 117 (2017)
|
> Prescrire's Response (117) |
• adavivint (replaced by lorecivivint in list 119)
• loxicodegol (replaced by oxycodegol in list 119)
• renapersen (replaced by renadirsen in list 120)
• votrisiran (replaced by vutrisiran in list 119) |
> List 116 (2017)
|
> Prescrire's Response (116) |
• tavolixizumab (replaced by tavolimab in list 118) |
> List 115 (2016)
|
> Prescrire's Response (115) |
|
> List 114 (2015)
|
> Prescrire's Response (114) |
• lendalizumab (replaced by olendalizumab in list 116)
• nalbuphine sebacate (replaced by dinalbuphine sebacate in list 116)
• pogalizumab (replaced by vonlerolizumab in list 116)
• raxatrigine (replaced by vixotrigine in list 116)
• sapélizumab (replaced by satralizumab in list 116) |
> List 113 (2015)
|
> Prescrire's Response (113) |
• fibatuzumab (replaced by ifabotuzumab in list 115) |
> List 112 (2014)
|
> Prescrire's Response (112) |
• asinercept (replaced by asunercept in list 114)
• erlosiban (replaced by nolasiban in list 114)
• ibiglustat (replaced by venglustat in list 114)
• lopixibat chloride (replaced by maralixibat chloride in list 113)
• neladenoson dalanate (replaced by neladenoson bialanate in list 113) |
| > List 111 (2014) |
> Prescrire's Response (111) |
• irbinitinib (replaced by tucatinib in list 113) |
| > List 110 (2013) |
> Prescrire's Response (110) |
• veruprevir (replaced by paritaprevir in list 111) |
| > List 109 (2013) |
> Prescrire's Response (109) |
• velcalcetide (replaced by etelcalcetide in list 112) |
| > List 108 (2012) |
> Prescrire's Response (108) |
|
| > List 107 (2012) |
> Prescrire's Response (107) |
• duligotumab (replaced by duligotuzumab in list 110)
• neceprevir (replaced by deldeprevir in list 110)
• saridegib (replaced by patidegib in list 111) |
| > List 106 (2011) |
> Prescrire's Response (106) |
|
| > List 105 (2011) |
> Prescrire's Response (105) |
|
| > List 104 (2010) |
> Prescrire's Response (104) |
• ronomilast (replaced by elbimilast in list 107) |
| > List 103 (2010) |
> Prescrire's Response (103) |
• tasocitinib (replaced by tofacitinib in list 105) |
| > List 102 (2009) |
> Prescrire's Response (102) |
• intedanib (replaced by nintedanib in list 105) |
| > List 101 (2009) |
> Prescrire's Response (101) |
|
| > List 100 (2008) |
> Prescrire's Response (100) |
|
| > List 99 (2008) |
> Prescrire's Response (99) |
• inolitazone (replaced by efatutazone in list 102) |
| > List 98 (2007) |
> Prescrire's Response (98)
|
• quarfloxine (replaced by itarnafloxine in list 103) |
| > List 97 (2007) |
> Prescrire's Response (97) |
|
